On October 19, 2010, the FDA approved a long-awaited new drug, dabigatran, expected to replace warfarin (Coumadin) as a better way to prevent blood clots in susceptible patients. This provides an opportunity to re-visit several issues that we have addressed before, including Big Pharma tactics, drug approval by the FDA,… read more "Dabigatran: A Promising Alternative to Warfarin"
Recombinant Human Antithrombin – Milking Nanny Goats for Big Bucks
Antithrombin deficiency is a hereditary disease causing low levels or defects of antithrombin, a blood protein required for controlling clot formation. Patients are at risk of blood clots, organ damage, and death. They usually have to take oral anticoagulant drugs like warfarin for life. During high-risk procedures like surgery or… read more "Recombinant Human Antithrombin – Milking Nanny Goats for Big Bucks"